Cell Line Lysates
Biochain Institute Inc Total Protein - Arrhythmia, infarct: Heart Atrium, left, 1 mg/PK
Tissue total protein is prepared from whole tissue homogenates. It presents a consistent pattern on SDS-PAGE analysis. The total protein is stored in a buffer with protease inhibitor cocktail, and provided at a concentration of 5 mg/ml.
Abcam Human RAB2A (Rab2) knockout HEK-293T cell lysate.
Human RAB2A (Rab2) knockout HEK-293T cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical GunIn-2-deoxyL-rIbofura 2.5mg
An isomer of dGTP and a telomerase inhibitor (Ki = 15 µM for the human enzyme)
Cayman Chemical DeoxyvIolaceIn 2.5mg
A bacterial metabolite with anticancer properties; inhibits proliferation of hepatocellular carcinoma cells when used at concentrations ranging from 0.1 to 1 µM; has antibacterial activity against Gram-positive bacteria when used at a concentration of 125 UG/ml; has antifungal activity when used at a concentration of 2 mg/ml
Abcam Human C17orf89 knockout HEK-293T cell lysate.
Human C17orf89 knockout HEK-293T cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Biochain Institute Inc Total Protein - Human Adult Normal Tissue: Liver, 1 mg/PK
Tissue total protein is prepared from whole tissue homogenates. It presents a consistent pattern on SDS-PAGE analysis. The total protein is stored in a buffer with protease inhibitor cocktail, and provided at a concentration of 5 mg/ml.
STEMCELL Technologies Human Platelet Lysate, Fibrinogen-Depleted, Size: 50 mL
Human platelet lysate is a growth factor-rich cell culture supplement derived from healthy donor human platelets at U.S. Food and Drug Administration (FDA)-licensed blood centers. Multiple donor units are pooled during manufacturing to minimize lot-to-lot variability. Pharmaceutical-grade heparin derived from porcine intestine is used in the manufacturing process. The concentration of heparin in the final product is ≤ 2 IU/mL.Certain products are only available in select territories. Please contact your local Sales representative or Product & Scientific Support at techsupport@stemcell.com for further information.
Abcam Human PGR (Progesterone Receptor) knockout HeLa cell lysate.
Human PGR (Progesterone Receptor) knockout HeLa cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
BPS Bioscience Inc BirA-transformed Competent *E. coli* cells, 10 x 50 μl vials, BL21(DE3) strain, 10 mM Na MOPS, pH 7.0, Storage -80°C, Antibiotic Resistance Streptomycin/spectinomycin
BirA-transformed Competent *E. coli* cells, 10 x 50 μl vials, BL21(DE3) strain, 10 mM Na MOPS, pH 7.0, Storage -80°C, Antibiotic Resistance Streptomycin/spectinomycin
Abcam Human PHLDA3 knockout HeLa cell lysate.
Human PHLDA3 knockout HeLa cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
ABclonal Technology 488 anti-Human CD171/L1CAM
The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family The ectodomain consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III) is linked via a single transmembrane sequence to a conserved cytoplasmic domain This cell adhesion molecule plays an important role in nervous system development including neuronal migration and differentiation Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia retardation aphasia spastic paraplegia and hydrocephalus) Alternative splicing of this gene results in multiple transcript variants some of which include an alternate exon that is considered to be specific to neurons
Cayman Chemical GIlvocarcIn M 2.5mg
An antibiotic; active against S. aureus bacteria at 32 UG/ml; inhibits growth of KB cells (IC50 = 0.52 UG/ml); intercalates into bacteriophage PM2 DNA; toxic to rats (LD50 = 450 mg/kg, i.v.)
Abcam Human C6orf62 knockout HeLa cell lysate.
Human C6orf62 knockout HeLa cell lysate.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical Mutnt IDH1-IN-1 50mg
An inhibitor of mutant IDH1 (IC50s = 42, 4, and 80 nM for IDH1R132H/R132H, IDH1R132C/R132C, and IDH1R132H/WT, respectively, for conversion of α-KG to 2-HG); selective for IDH1 mutant conversion of α-KG to 2-HT over IDH1WT/WT conversion of isocitrate to α-KG (IC50 = 1,998 nM) and over IDH2 (IC50s = >10,000 nM); inhibits 2-HG production in vitro (IC50 = 81.5 nM)